Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
ERIS
ERIS

Eris Lifesciences Ltd.

NSE: ERIS
BSE: 540596
Sector: Healthcare
Industry: Pharmaceuticals
1,413.90-21.2 (-1.48%)
8 Jul, 12:00 AM

Stock Scores

Quality Score

86.8 / 100

Value Score

26.3 / 100

Price Momentum Score

51.2 / 100

QVM Score

56.5 / 100

Key Metrics

Market Cap
19593.50
P/E (TTM)
31.63
P/B
5.02
P/S (TTM)
6.26
EV/EBITDA
19.53
CAPE (5Y)
44.80
ROE (TTM)
18.32
ROCE (TTM)
14.00
ROA (TTM)
8.61
Avg 3Y ROE
15.88
Earnings 3Y CAGR
17.27
Sales 3Y CAGR
22.92
Sales 5Y CAGR
20.89
Debt/Equity
0.60
Consensus TP
1730.00
Strong Buy %
50.00
Promoter Holding
53.92
Pledged %
16.92

Share Price

Track Eris Lifesciences Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -2.25 %
Low
1,395.0
High
1,465.0
1 Month returns: 3.57 %
Low
1,337.6
High
1,488.1
1 Year returns: -17.51 %
Low
1,200.0
High
1,887.7
3 Year CAGR: 24.94 %
Low
693.0
High
1,910.0
5 Year CAGR: 13.43 %
Low
551.3
High
1,910.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Eris Lifesciences Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Eris Lifesciences Ltd. Shareholding Pattern

Quarterly breakdown of Eris Lifesciences Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Eris Lifesciences Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Eris Lifesciences Ltd.?
The current share price of Eris Lifesciences Ltd. is ₹ 1,413.90 as of 8 Jul 2026.
What is the market capitalisation of Eris Lifesciences Ltd.?
The market capitalisation of Eris Lifesciences Ltd. stands at ₹ 19,593.50 Cr.
What is the PE ratio of Eris Lifesciences Ltd.?
The Price-to-Earnings (PE) ratio of Eris Lifesciences Ltd. is 31.63 as of the latest trailing twelve months data.
What is the ROE and ROCE of Eris Lifesciences Ltd.?
Eris Lifesciences Ltd. has a Return on Equity (ROE) of 18.32% and a Return on Capital Employed (ROCE) of 14.00% as per the latest financial reports.
What is the 52-week high and low of Eris Lifesciences Ltd.?
The 52-week high of Eris Lifesciences Ltd. is - and the 52-week low is -.
What is the dividend yield of Eris Lifesciences Ltd.?
The dividend yield of Eris Lifesciences Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Eris Lifesciences Ltd.?
Foreign Institutional Investors (FII) hold 6.39%, Domestic Institutional Investors (DII) hold 19.53% and retail/public investors hold 19.06% of Eris Lifesciences Ltd. shares.
What sector does Eris Lifesciences Ltd. belong to?
Eris Lifesciences Ltd. operates in the Healthcare sector. 90% of analysts have a Buy or Strong Buy rating on Eris Lifesciences Ltd. with a consensus target price of ₹ 1,730.00, implying 22.36% upside from current levels.
What is the beta of Eris Lifesciences Ltd.?
The beta of Eris Lifesciences Ltd. is 0.55, indicating its price volatility relative to the broader market. Over the past 1 year, Eris Lifesciences Ltd. has delivered an absolute return of -16.03%.
What is the RSI of Eris Lifesciences Ltd.?
The 14-day Relative Strength Index (RSI) of Eris Lifesciences Ltd. is 49.65, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.